These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20699387)

  • 1. Targeting the endothelium to prevent diabetes-related atherosclerosis.
    Kearney MT
    Diab Vasc Dis Res; 2010 Jul; 7(3):177. PubMed ID: 20699387
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction and cardiovascular disease--the lull before the storm.
    Marx N; Grant PJ
    Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling.
    Csiszar A; Ungvari Z
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H475-6. PubMed ID: 18599592
    [No Abstract]   [Full Text] [Related]  

  • 5. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.
    Leo CH; Woodman OL
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):532-44. PubMed ID: 25387248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reactivity in diabetes mellitus.
    Dandona P
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():12-4. PubMed ID: 20629223
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Zaccardi F; Pitocco D; Caputo S; Ghirlanda G
    Diabet Med; 2011 Jan; 28(1):126; author reply 127-8. PubMed ID: 21166858
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelial dysfunction and its role in diabetic vascular disease.
    Hartge MM; Kintscher U; Unger T
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on endothelial function in impaired glucose tolerance.
    Quinn CE; Lockhart CJ; Hamilton PK; Loughrey CM; McVeigh GE
    Diabetes Obes Metab; 2010 Aug; 12(8):709-15. PubMed ID: 20590748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents.
    Dandona P; Aljada A
    J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance and atherosclerosis. Controlling diabetes on 2 fronts].
    MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584452
    [No Abstract]   [Full Text] [Related]  

  • 12. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF; Lohray BB
    J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study.
    Li F; Zhao T; Wen X
    Diabetes Res Clin Pract; 2011 Nov; 94(2):186-92. PubMed ID: 21871685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
    J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and hypertension in diabetes mellitus.
    Dandona P; Chaudhuri A; Aljada A
    Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
    Campbell IW; Charbonnel B
    Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.
    Dong Y; Fernandes C; Liu Y; Wu Y; Wu H; Brophy ML; Deng L; Song K; Wen A; Wong S; Yan D; Towner R; Chen H
    Diab Vasc Dis Res; 2017 Jan; 14(1):14-23. PubMed ID: 27941052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.